![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
DOES NESIRITIDE HAS THE POTENTIAL FOR TREATING HEPATIC SINUSOIDAL OBSTRUCTION SYNDROME IN CONJUNCTION WITH TIROFIBAN?*Manoj G Tyagi and Bhavapriya R Department of Pharmacology, Christian Medical College, Vellore 632002, Tamilnadu India. ABSTRACT The hepatic sinusoidal obstruction syndrome (SOS) also known as veno-occlusive disease (VOD) is characterized by jaundice, ascites and hepatomegaly. The incidence of SOS during hematopoietic cell transplantation varies depending upon the center and the definitions used for making a diagnosis. Rates as high as 50 percent have been reported, the current treatment for VOD is tissue plasminogen activator (t-PA) and cyclosporine. Apart from this defibrotide is an investigational treatment that may be promising. Defibrotide is a polydeoxyribonucleotide isolated from pig intestine.In this article we speculate the potential use of Nesiritide a 32 amino acid synthetic Brain natriuretic peptide analogue along with Tirofiban for treating the syndrome of VOD. Keywords: Hepatic, Nesiritide, Tirofiban, Venules, jaundice. [Download Article] [Download Certifiate] |